Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NNOX Nano-X Imaging	$4.26 -3.6%	$5.05	$3.75 ▼ $11.00	$246.14M	1.95	1.78 million shs	1.55 million shs
NYXH Nyxoah	$6.57 +5.6%	$7.57	$5.55 ▼ $11.87	$223.77M	1.61	106,248 shs	128,636 shs
SKIN Beauty Health	$2.19 +0.5%	$1.84	$0.78 ▼ $2.56	$277.74M	1.2	862,172 shs	609,127 shs
TELA TELA Bio	$1.70 +7.6%	$1.86	$0.86 ▼ $3.26	$67.35M	0.93	177,502 shs	139,064 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NNOX Nano-X Imaging	0.00%	-4.95%	-14.01%	-19.34%	-38.70%
NYXH Nyxoah	0.00%	-16.17%	-24.33%	-8.39%	-20.05%
SKIN Beauty Health	0.00%	+15.34%	+37.11%	+32.93%	+54.61%
TELA TELA Bio	0.00%	-8.14%	-25.82%	+37.39%	-49.20%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
NNOX Nano-X Imaging	2.127 of 5 stars	3.8	2.0	2.2	0.0	0.6
NYXH Nyxoah	2.8007 of 5 stars	3.5	3.0	2.4	0.0	0.6
SKIN Beauty Health	1.0929 of 5 stars	2.0	0.0	3.3	3.3	0.0
TELA TELA Bio	2.7352 of 5 stars	3.3	4.0	2.2	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
NNOX Nano-X Imaging	3.50	Strong Buy	$8.50	99.53% Upside
NYXH Nyxoah	3.00	Buy	$15.00	128.31% Upside
SKIN Beauty Health	2.00	Hold	$2.63	19.86% Upside
TELA TELA Bio	2.50	Moderate Buy	$4.50	164.71% Upside

Current Analyst Ratings Breakdown

Latest TELA, NNOX, NYXH, and SKIN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
8/11/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/1/2025	SKIN Beauty Health	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$3.00 ➝ $4.00
7/14/2025	NNOX Nano-X Imaging	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/6/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00
5/22/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
NNOX Nano-X Imaging	$11.28M	21.82	N/A	N/A	$3.27 per share	1.30
NYXH Nyxoah	$4.89M	45.76	N/A	N/A	$3.60 per share	1.83
SKIN Beauty Health	$334.30M	0.83	$0.06 per share	34.48	$0.41 per share	5.34
TELA TELA Bio	$69.30M	0.97	N/A	N/A	$0.72 per share	2.36

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
NNOX Nano-X Imaging	-$53.52M	-$0.90	N/A	N/A	N/A	-468.29%	-32.09%	-28.73%	N/A
NYXH Nyxoah	-$64.10M	-$2.13	N/A	N/A	N/A	-1,571.39%	-63.37%	-46.67%	8/18/2025 (Estimated)
SKIN Beauty Health	-$29.10M	-$0.28	N/A	N/A	N/A	-6.13%	-32.82%	-2.96%	N/A
TELA TELA Bio	-$37.84M	-$1.12	N/A	N/A	N/A	-54.12%	-329.48%	-57.34%	11/6/2025 (Estimated)

Latest TELA, NNOX, NYXH, and SKIN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2025	Q2 2025	NYXH Nyxoah	-$0.60	-$0.63	-$0.03	-$0.63	$1.33 million	N/A
8/12/2025	Q2 2025	NNOX Nano-X Imaging	-$0.15	-$0.23	-$0.08	-$0.23	$3.20 million	$3.04 million
8/11/2025	Q2 2025	TELA TELA Bio	-$0.18	-$0.22	-$0.04	-$0.22	$20.67 million	$20.20 million
8/7/2025	Q2 2025	SKIN Beauty Health	-$0.06	$0.03	+$0.09	$0.03	$74.67 million	$78.20 million
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A
SKIN Beauty Health	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
NNOX Nano-X Imaging	N/A	4.19	4.03
NYXH Nyxoah	0.22	3.59	3.35
SKIN Beauty Health	4.91	5.15	4.15
TELA TELA Bio	4.14	3.19	2.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
NNOX Nano-X Imaging	21.49%
NYXH Nyxoah	N/A
SKIN Beauty Health	93.26%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
NNOX Nano-X Imaging	N/A
NYXH Nyxoah	N/A
SKIN Beauty Health	41.00%
TELA TELA Bio	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
NNOX Nano-X Imaging	190	57.78 million	N/A	Optionable
NYXH Nyxoah	110	34.06 million	N/A	Not Optionable
SKIN Beauty Health	1,030	126.82 million	74.83 million	Optionable
TELA TELA Bio	120	39.62 million	37.75 million	Optionable

TELA, NNOX, NYXH, and SKIN Headlines

Recent News About These Companies

Tela Bio reports Q2 EPS (22c), consensus (19c)

August 13, 2025 | msn.com

TELA Bio (NASDAQ:TELA) Issues Earnings Results

August 12, 2025 | marketbeat.com

Tela Bio backs FY25 revenue view $85M-$88M, consensus $86.05M

August 12, 2025 | msn.com

Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates

August 12, 2025 | msn.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2025 | zacks.com

TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript

August 11, 2025 | seekingalpha.com

TELA Bio Reports Second Quarter 2025 Financial Results

August 11, 2025 | globenewswire.com

TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect

August 10, 2025 | finance.yahoo.com

TELA Bio Awards Inducement Equity Grants to New Employees

August 10, 2025 | msn.com

TELA Bio (TELA) Projected to Post Earnings on Monday

August 9, 2025 | americanbankingnews.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2025 | globenewswire.com

TELA Bio (TELA) Expected to Announce Quarterly Earnings on Monday

August 5, 2025 | marketbeat.com

TELA Bio (NASDAQ:TELA) Trading 4.2% Higher - Time to Buy?

July 30, 2025 | marketbeat.com

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 23, 2025 | globenewswire.com

AIGH Capital Management LLC Sells 1,246,462 Shares of TELA Bio, Inc. (NASDAQ:TELA)

July 22, 2025 | marketbeat.com

TELA Bio to Announce Second Quarter 2025 Financial Results

July 21, 2025 | globenewswire.com

TELA Bio, Inc. (TELA) Latest Stock News & Headlines - Yahoo Finance

July 19, 2025 | finance.yahoo.com

Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)

July 3, 2025 | finance.yahoo.com

TELA Bio Welcomes Jim Hagen with Strategic Equity Grant

June 9, 2025 | msn.com

TELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 7, 2025 | finanznachrichten.de

TELA Bio, Inc. Grants Inducement Equity Awards to New Senior Vice President Jim Hagen

June 6, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA, NNOX, NYXH, and SKIN Company Descriptions

Nano-X Imaging NASDAQ:NNOX

$4.26 -0.16 (-3.62%)

Closing price 04:00 PM Eastern

Extended Trading

$4.30 +0.04 (+0.94%)

As of 04:42 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Nyxoah NASDAQ:NYXH

$6.57 +0.35 (+5.63%)

Closing price 04:00 PM Eastern

Extended Trading

$6.66 +0.09 (+1.29%)

As of 04:33 PM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Beauty Health NASDAQ:SKIN

$2.19 +0.01 (+0.46%)

Closing price 04:00 PM Eastern

Extended Trading

$2.19 +0.00 (+0.23%)

As of 04:10 PM Eastern

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

TELA Bio NASDAQ:TELA

$1.70 +0.12 (+7.59%)

Closing price 04:00 PM Eastern

Extended Trading

$1.67 -0.03 (-1.76%)

As of 04:04 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time